Neurogene Inc. (NGNE) › Shareholders' EquityNeurogene Inc. (NGNE) — Shareholders' EquityAnnual figures by fiscal year, from SEC filings.2011: -$39.31M2012: -$51.10M2013: -$65.69M2014: $36.15M2015: $108.42M2016: $144.66M2017: $98.89M2018: $72.67M2019: $141.69M2020: $191.22M2021: -$91.88M2022: -$145.74M2023: $186.02M2024: $310.38M2025: $264.89M$264.89M2011Shareholders' Equity (USD)2025Fiscal YearShareholders' EquityChange YoY2025$264.89M-14.7%2024$310.38M+66.8%2023$186.02M+227.6%2022-$145.74M-58.6%2021-$91.88M-148.0%2020$191.22M+35.0%2019$141.69M+95.0%2018$72.67M-26.5%2017$98.89M-31.6%2016$144.66M+33.4%2015$108.42M+199.9%2014$36.15M+155.0%2013-$65.69M-28.6%2012-$51.10M-30.0%2011-$39.31M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share